9
Nov
2027
Messe, Frankfurt
9 - 11 November 2027
stand 80G55

Yuxi Walvax Biotechnology Co., Ltd.

About Yuxi Walvax Biotechnology Co., Ltd.

Founded in 2001, Walvax Biotechnology Co. Ltd. is mainly engaged in research and development, manufacturing and distribution of safe and efficacious human vaccines. Walvax is a leading public listed company in China and has successfully developed 9 licensed vaccines (13 presentations). Among the 9 licensed products, Walvax has world’s 2nd approved PCV-13, 4th approved mRNA Covid-19 vaccine and 5th approved HPV vaccine. 

Meet us at

  • CPHI Frankfurt 2027

    Messe, Frankfurt
    9 - 11 November 2027
    stand 80G55
  • Country/Region:
    China
  • On CPHI since:
    2023
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
Contact info

Products from Yuxi Walvax Biotechnology Co., Ltd. (3)